NEXELL THERAPEUTICS
Nexell Therapeutics, Inc. operates as a biotechnology company whose principal subsidiary, Nexell of California, Inc. (NCI) engages in the development of cell therapy products for the treatment of genetic blood disorders, autoimmune diseases, cancer and regenerative medicine applications. Its lead candidate product in Phase III clinical trials is a proprietary cellular product comprised of CD34+ hematopoietic stem cells (HSC) for treatment of chronic granulomatous disease, a life-threatening here... ditary disorder. NCI is also developing dendritic cell vaccines for the treatment of certain cancers. In this program, NCI is applying proprietary technology to isolate dendritic cell precursors, activate them ex vivo and transform them into mature dendritic cells suitable for reinfusion into the patient. The initial candidate vaccine is targeting colon cancer. Also, NCI has a preclinical development program for a companion to the HSC stem cell product that is intended for stabilization and maintenance of donor cells.
NEXELL THERAPEUTICS
Industry:
Biotechnology Genetics Medical Pharmaceutical
Founded:
1986-12-30
Address:
Irvine, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Contact:
(949)470-9011
Total Funding:
850 K USD
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
PanTheryx
PanTheryx is a nutrition and biotechnology company that utilizes the cellular and biomolecular processes of bovine colostrum.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Employees Featured
More informations about "Nexell Therapeutics"
Nexell Therapeutics - Crunchbase Company Profile & Funding
Nexell Therapeutics, Inc. operates as a biotechnology company whose principal subsidiary, Nexell of California, Inc. (NCI) engages in the development of cell therapy products for the treatment …See details»
Nexell Therapeutics Company Profile 2024: Valuation, Investors ...
Information on acquisition, funding, investors, and executives for Nexell Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Nexell Therapeutics - Funding, Financials, Valuation & Investors
Nexell Therapeutics, Inc. operates as a biotechnology company whose principal subsidiary, Nexell of California, Inc.See details»
Nexell Therapeutics Inc - Company Profile and News
Company profile page for Nexell Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
Nexell Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Nexell Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, and 16 literature, Drug:p47/gp91 gene therapy(Nexell Therapeutics, Inc.), VM …See details»
Vimrx Hopes Investors Take Notice Of Move Into Nexell
Jan 19, 1999 · Vimrx Pharmaceuticals Inc. is acquiring Baxter Healthcare Corp.'s minority interest in Nexell Therapeutics Inc. as part of a move to consolidate all its operations into Nexell.See details»
Nexell becomes free-standing company with Baxter support
May 17, 1999 · Nexell Therapeutics is set to become a free-standing cell therapy company as Baxter, which owns a minority share in Nexell, transfers sales and marketing rights back to …See details»
Nexell Therapeutics - Crunchbase
Nexell Therapeutics, Inc. operates as a biotechnology company whose principal subsidiary, Nexell of California, Inc.See details»
Nexell Therapeutics Inc. - BioCentury Company Profiles - BCIQ
Oct 21, 2002 · Nexell Therapeutics Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Nexell Will Wind Down Its Operations - Los Angeles Times
May 16, 2002 · The Irvine-based biotechnology company said its work force will be cut from 23 employees to three as a first step. Nexell is considering such alternatives as liquidation, …See details»
In Brief: Nexell Therapeutics :: Medtech Insight
Mar 23, 1998 · Nexell Therapeutics: Baxter/VimRx cell therapy joint venture submits a premarket approval application supplement to a pending PMA for the Isolex 300 semi-automated stem …See details»
Nexell Therapeutics - Updates, News, Events, Signals & Triggers
May 23, 2016 · Nexell Therapeutics, Inc. operates as a biotechnology company whose principal subsidiary, Nexell of California, Inc.See details»
Nexell's shares lifted by FDA decision - MarketWatch
IRIVINE, Calif. (CBS.MW) -- Shares of Nexell Therapeutics Inc. surged more than 200 percent Wednesday, after the small biotech firm said its experimental treatment for a blood disorder had...See details»
Manufacture of Autologous CD34 - National Center for …
We assessed comparability of flow cytometry and controlled rate cryopreservation among sites and stability of cryopreserved grafts using hematopoietic progenitor cells (HPCs) from healthy …See details»
FDA Boosts Nexell With “Orphan Drug” Designation
Dec 2, 2001 · Shares of Nexell Therapeutics Inc., an Irvine-based drug developer, got a boost late last week after the Food and Drug Administration granted "orphan drug" status to one of the …See details»
The Business of Stem Cells | Science - AAAS
Feb 25, 2000 · Typical of this group are Nexell Therapeutics Inc. of Irvine, California, and Aastrom Biosciences of Ann Arbor, Michigan, both of which are developing systems to isolate such …See details»
Patents Assigned to Nexell Therapeutics Inc.
Sep 25, 2002 · Abstract: The present invention provides peptide-ligand conjugates containing a peptide, where a free form of the peptide is capable of displacing a second ligand specific for …See details»
Nexell Therapeutics - Tech Stack, Apps, Patents & Trademarks
Nexell Therapeutics, Inc. operates as a biotechnology company whose principal subsidiary, Nexell of California, Inc.See details»
Amy Ross - Title IX: 50 Years of Progress
Mar 29, 2023 · She said she feels fortunate that she did not encounter many incidents of harassment during a nearly three-decade-long career that saw her serve as senior vice …See details»
Nexell Therapeutics - Contacts, Employees, Board Members
Nexell Therapeutics, Inc. operates as a biotechnology company whose principal subsidiary, Nexell of California, Inc.See details»